RecruitingNot ApplicableNCT06544057

Real-time eCounselling for Nicotine Addiction

Real-time eCounselling for Nicotine Addiction: a Feasibility Study and Pilot RCT


Sponsor

Overcome

Enrollment

60 participants

Start Date

Jul 8, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to pilot an eHealth intervention (real-time telecounselling) in nicotine addiction. The main questions it aims to answer are: Is the intervention likely to be efficacious in preventing an increase in Abstinence? Is the intervention likely to be efficacious in preventing an increase in nicotine consumption? Is the intervention likely to be efficacious in influencing Readiness to quit nicotine? How feasible is the intervention for developing a larger-scale trial? Researchers will compare a range of outcome measures between the active and control arms, to see if a pilot eHealth intervention can successfully treat nicotine addiction.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria5

  • Age: 18-65 Years old
  • Self Reported smoking ≥ 5 cigarettes per day, or regular vaper of > 0mg nicotine
  • Desire to quit nicotine consumption
  • Willing to set a quit date
  • Able to provide written informed consent to participate -

Exclusion Criteria5

  • Enrolled in another behavioural intervention programme
  • Pregnant, breastfeeding or planning to become pregnant.
  • Individuals currently experiencing a problematic relationship with alcohol or drugs
  • Documented Cognitive Impairment
  • Individuals with a PHQ-9 score of ≥ 14 or a GAD-7 score of >12.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCBT-MI

CBT-MI combines elements from Cognitive Behavioural Therapy and Motivational Interviewing in treating nicotine addiction, delivered remotely via Zoom by trained 'layperson coaches'


Locations(1)

Key contact

Leicester, Midlands, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06544057


Related Trials